PremiumThe FlyAvid Bioservices says ISS, Glass Lewis recommend vote ‘FOR’ transaction Avid Bioservices announces expiration of HSR waiting period for acquisition Avid Bioservices Reports Revenue Growth Amid Acquisition Plans PremiumCompany AnnouncementsAvid Bioservices to be Acquired in $1.1 Billion Deal Avid Bioservices downgraded to Sector Perform from Outperform at RBC Capital Avid Bioservices trading resumes PremiumThe FlyBiotech Alert: Searches spiking for these stocks today Biotech Alert: Searches spiking for these stocks today Avid Bioservices price target raised to $12 from $8 at RBC Capital